{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,23]],"date-time":"2026-03-23T11:18:25Z","timestamp":1774264705318,"version":"3.50.1"},"reference-count":23,"publisher":"Springer Science and Business Media LLC","issue":"1","content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Cancer"],"published-print":{"date-parts":[[2010,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:sec>\n            <jats:title>Background<\/jats:title>\n            <jats:p>PCBP1 (or alpha CP1 or hnRNP E1), a member of the PCBP family, is widely expressed in many human tissues and involved in regulation of transcription, transportation process, and function of RNA molecules. However, the role of PCBP1 in CD44 variants splicing still remains elusive.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results<\/jats:title>\n            <jats:p>We found that enforced PCBP1 expression inhibited CD44 variants expression including v3, v5, v6, v8, and v10 in HepG2 cells, and knockdown of endogenous PCBP1 induced these variants splicing. Invasion assay suggested that PCBP1 played a negative role in tumor invasion and re-expression of v6 partly reversed the inhibition effect by PCBP1. A correlation of PCBP1 down-regulation and v6 up-regulation was detected in primary HCC tissues.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusions<\/jats:title>\n            <jats:p>We first characterized PCBP1 as a negative regulator of CD44 variants splicing in HepG2 cells, and loss of PCBP1 in human hepatic tumor contributes to the formation of a metastatic phenotype.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1186\/1476-4598-9-72","type":"journal-article","created":{"date-parts":[[2010,4,2]],"date-time":"2010-04-02T18:13:50Z","timestamp":1270232030000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":77,"title":["PCBP-1 regulates alternative splicing of the CD44 gene and inhibits invasion in human hepatoma cell line HepG2 cells"],"prefix":"10.1186","volume":"9","author":[{"given":"Tong","family":"Zhang","sequence":"first","affiliation":[]},{"given":"Xian-Hong","family":"Huang","sequence":"additional","affiliation":[]},{"given":"Lan","family":"Dong","sequence":"additional","affiliation":[]},{"given":"Deqing","family":"Hu","sequence":"additional","affiliation":[]},{"given":"Changhui","family":"Ge","sequence":"additional","affiliation":[]},{"given":"Yi-Qun","family":"Zhan","sequence":"additional","affiliation":[]},{"given":"Wang-Xiang","family":"Xu","sequence":"additional","affiliation":[]},{"given":"Miao","family":"Yu","sequence":"additional","affiliation":[]},{"given":"Wei","family":"Li","sequence":"additional","affiliation":[]},{"given":"Xiaohui","family":"Wang","sequence":"additional","affiliation":[]},{"given":"Liujun","family":"Tang","sequence":"additional","affiliation":[]},{"given":"Chang-Yan","family":"Li","sequence":"additional","affiliation":[]},{"given":"Xiao-Ming","family":"Yang","sequence":"additional","affiliation":[]}],"member":"297","published-online":{"date-parts":[[2010,4,2]]},"reference":[{"key":"587_CR1","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1038\/nrm1004","volume":"4","author":"H Ponta","year":"2003","unstructured":"Ponta H, Sherman L, Herrlich PA: CD44: from adhesion molecules to signalling regulators. Nat Rev Mol Cell Biol. 2003, 4: 33-45. 10.1038\/nrm1004","journal-title":"Nat Rev Mol Cell Biol"},{"key":"587_CR2","doi-asserted-by":"publisher","first-page":"687","DOI":"10.1083\/jcb.128.4.687","volume":"128","author":"KL Bennett","year":"1995","unstructured":"Bennett KL, Jackson DG, Simon JC, Tanczos E, Peach R, Modrell B, Stamenkovic I, Plowman G, Aruffo A: CD44 isoforms containing exon V3 are responsible for the presentation of heparin-binding growth factor. J Cell Biol. 1995, 128: 687-698. 10.1083\/jcb.128.4.687","journal-title":"J Cell Biol"},{"key":"587_CR3","doi-asserted-by":"publisher","first-page":"e1826","DOI":"10.1371\/journal.pone.0001826","volume":"3","author":"K Zen","year":"2008","unstructured":"Zen K, Liu DQ, Guo YL, Wang C, Shan J, Fang M, Zhang CY, Liu Y: CD44v4 is a major E-selectin ligand that mediates breast cancer cell transendothelial migration. PLoS One. 2008, 3: e1826. 10.1371\/journal.pone.0001826","journal-title":"PLoS One"},{"key":"587_CR4","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1016\/0092-8674(91)90403-L","volume":"65","author":"U Gunthert","year":"1991","unstructured":"Gunthert U, Hofmann M, Rudy W, Reber S, Zoller M, Haussmann I, Matzku S, Wenzel A, Ponta H, Herrlich P: A new variant of glycoprotein CD44 confers metastatic potential to rat carcinoma cells. Cell. 1991, 65: 13-24. 10.1016\/0092-8674(91)90403-L","journal-title":"Cell"},{"key":"587_CR5","doi-asserted-by":"publisher","first-page":"3074","DOI":"10.1101\/gad.242602","volume":"16","author":"V Orian-Rousseau","year":"2002","unstructured":"Orian-Rousseau V, Chen L, Sleeman JP, Herrlich P, Ponta H: CD44 is required for two consecutive steps in HGF\/c-Met signaling. Genes Dev. 2002, 16: 3074-3086. 10.1101\/gad.242602","journal-title":"Genes Dev"},{"key":"587_CR6","first-page":"1576","volume":"63","author":"JA Recio","year":"2003","unstructured":"Recio JA, Merlino G: Hepatocyte growth factor\/scatter factor induces feedback up-regulation of CD44v6 in melanoma cells through Egr-1. Cancer Res. 2003, 63: 1576-1582.","journal-title":"Cancer Res"},{"key":"587_CR7","doi-asserted-by":"publisher","first-page":"968","DOI":"10.1101\/gad.189601","volume":"15","author":"H Morrison","year":"2001","unstructured":"Morrison H, Sherman LS, Legg J, Banine F, Isacke C, Haipek CA, Gutmann DH, Ponta H, Herrlich P: The NF2 tumor suppressor gene product, merlin, mediates contact inhibition of growth through interactions with CD44. Genes Dev. 2001, 15: 968-980. 10.1101\/gad.189601","journal-title":"Genes Dev"},{"key":"587_CR8","doi-asserted-by":"publisher","first-page":"1715","DOI":"10.1101\/gad.1430906","volume":"20","author":"C Cheng","year":"2006","unstructured":"Cheng C, Yaffe MB, Sharp PA: A positive feedback loop couples Ras activation and CD44 alternative splicing. Genes Dev. 2006, 20: 1715-1720. 10.1101\/gad.1430906","journal-title":"Genes Dev"},{"key":"587_CR9","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1111\/j.1432-1033.1995.tb20581.x","volume":"230","author":"H Leffers","year":"1995","unstructured":"Leffers H, Dejgaard K, Celis JE: Characterisation of two major cellular poly(rC)-binding human proteins, each containing three K-homologous (KH) domains. Eur J Biochem. 1995, 230: 447-453. 10.1111\/j.1432-1033.1995.tb20581.x","journal-title":"Eur J Biochem"},{"key":"587_CR10","doi-asserted-by":"publisher","first-page":"41510","DOI":"10.1074\/jbc.M106824200","volume":"276","author":"X Xiao","year":"2001","unstructured":"Xiao X, Tang YS, Mackins JY, Sun XL, Jayaram HN, Hansen DK, Antony AC: Isolation and characterization of a folate receptor mRNA-binding trans-factor from human placenta. Evidence favoring identity with heterogeneous nuclear ribonucleoprotein E1. J Biol Chem. 2001, 276: 41510-41517. 10.1074\/jbc.M106824200","journal-title":"J Biol Chem"},{"key":"587_CR11","doi-asserted-by":"crossref","first-page":"4030","DOI":"10.1002\/j.1460-2075.1996.tb00776.x","volume":"15","author":"H Konig","year":"1996","unstructured":"Konig H, Moll J, Ponta H, Herrlich P: Trans-acting factors regulate the expression of CD44 splice variants. Embo J. 1996, 15: 4030-4039.","journal-title":"Embo J"},{"key":"587_CR12","doi-asserted-by":"publisher","first-page":"4194","DOI":"10.1093\/emboj\/20.15.4194","volume":"20","author":"S Weg-Remers","year":"2001","unstructured":"Weg-Remers S, Ponta H, Herrlich P, Konig H: Regulation of alternative pre-mRNA splicing by the ERK MAP-kinase pathway. Embo J. 2001, 20: 4194-4203. 10.1093\/emboj\/20.15.4194","journal-title":"Embo J"},{"key":"587_CR13","doi-asserted-by":"publisher","first-page":"35353","DOI":"10.1074\/jbc.M004692200","volume":"275","author":"N Matter","year":"2000","unstructured":"Matter N, Marx M, Weg-Remers S, Ponta H, Herrlich P, Konig H: Heterogeneous ribonucleoprotein A1 is part of an exon-specific splice-silencing complex controlled by oncogenic signaling pathways. J Biol Chem. 2000, 275: 35353-35360. 10.1074\/jbc.M004692200","journal-title":"J Biol Chem"},{"key":"587_CR14","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1016\/S0968-0004(00)01604-2","volume":"25","author":"CW Smith","year":"2000","unstructured":"Smith CW, Valcarcel J: Alternative pre-mRNA splicing: the logic of combinatorial control. Trends Biochem Sci. 2000, 25: 381-388. 10.1016\/S0968-0004(00)01604-2","journal-title":"Trends Biochem Sci"},{"key":"587_CR15","doi-asserted-by":"publisher","first-page":"5866","DOI":"10.1073\/pnas.0701065104","volume":"104","author":"Q Meng","year":"2007","unstructured":"Meng Q, Rayala SK, Gururaj AE, Talukder AH, O'Malley BW, Kumar R: Signaling-dependent and coordinated regulation of transcription, splicing, and translation resides in a single coregulator, PCBP1. Proc Natl Acad Sci USA. 2007, 104: 5866-5871. 10.1073\/pnas.0701065104","journal-title":"Proc Natl Acad Sci USA"},{"key":"587_CR16","doi-asserted-by":"publisher","first-page":"567","DOI":"10.1007\/s00262-003-0494-4","volume":"53","author":"KH Heider","year":"2004","unstructured":"Heider KH, Kuthan H, Stehle G, Munzert G: CD44v6: a target for antibody-based cancer therapy. Cancer Immunol Immunother. 2004, 53: 567-579. 10.1007\/s00262-003-0494-4","journal-title":"Cancer Immunol Immunother"},{"key":"587_CR17","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1111\/j.1432-1033.1996.00425.x","volume":"241","author":"K Dejgaard","year":"1996","unstructured":"Dejgaard K, Leffers H: Characterisation of the nucleic-acid-binding activity of KH domains. Different properties of different domains. Eur J Biochem. 1996, 241: 425-431. 10.1111\/j.1432-1033.1996.00425.x","journal-title":"Eur J Biochem"},{"key":"587_CR18","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1006\/jmbi.2000.3687","volume":"298","author":"JH Kim","year":"2000","unstructured":"Kim JH, Hahm B, Kim YK, Choi M, Jang SK: Protein-protein interaction among hnRNPs shuttling between nucleus and cytoplasm. J Mol Biol. 2000, 298: 395-405. 10.1006\/jmbi.2000.3687","journal-title":"J Mol Biol"},{"key":"587_CR19","doi-asserted-by":"publisher","first-page":"569","DOI":"10.1136\/jcp.56.8.569","volume":"56","author":"MR Pillai","year":"2003","unstructured":"Pillai MR, Chacko P, Kesari LA, Jayaprakash PG, Jayaram HN, Antony AC: Expression of folate receptors and heterogeneous nuclear ribonucleoprotein E1 in women with human papillomavirus mediated transformation of cervical tissue to cancer. J Clin Pathol. 2003, 56: 569-574. 10.1136\/jcp.56.8.569","journal-title":"J Clin Pathol"},{"key":"587_CR20","doi-asserted-by":"publisher","first-page":"651","DOI":"10.1093\/carcin\/bgg008","volume":"24","author":"KA Peebles","year":"2003","unstructured":"Peebles KA, Duncan MW, Ruch RJ, Malkinson AM: Proteomic analysis of a neoplastic mouse lung epithelial cell line whose tumorigenicity has been abrogated by transfection with the gap junction structural gene for connexin 43, Gja1. Carcinogenesis. 2003, 24: 651-657. 10.1093\/carcin\/bgg008","journal-title":"Carcinogenesis"},{"key":"587_CR21","doi-asserted-by":"publisher","first-page":"1798","DOI":"10.1074\/mcp.M600449-MCP200","volume":"6","author":"W Sun","year":"2007","unstructured":"Sun W, Xing B, Sun Y, Du X, Lu M, Hao C, Lu Z, Mi W, Wu S, Wei H: Proteome analysis of hepatocellular carcinoma by two-dimensional difference gel electrophoresis: novel protein markers in hepatocellular carcinoma tissues. Mol Cell Proteomics. 2007, 6: 1798-1808. 10.1074\/mcp.M600449-MCP200","journal-title":"Mol Cell Proteomics"},{"key":"587_CR22","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1016\/j.yexcr.2003.11.011","volume":"294","author":"B Honore","year":"2004","unstructured":"Honore B, Baandrup U, Vorum H: Heterogeneous nuclear ribonucleoproteins F and H\/H' show differential expression in normal and selected cancer tissues. Exp Cell Res. 2004, 294: 199-209. 10.1016\/j.yexcr.2003.11.011","journal-title":"Exp Cell Res"},{"key":"587_CR23","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1053\/hupa.2001.21132","volume":"32","author":"T Pesti","year":"2001","unstructured":"Pesti T, Sukosd F, Jones EC, Kovacs G: Mapping a tumor suppressor gene to chromosome 2p13 in metanephric adenoma by microsatellite allelotyping. Hum Pathol. 2001, 32: 101-104. 10.1053\/hupa.2001.21132","journal-title":"Hum Pathol"}],"container-title":["Molecular Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/1476-4598-9-72.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T05:09:49Z","timestamp":1630472989000},"score":1,"resource":{"primary":{"URL":"https:\/\/molecular-cancer.biomedcentral.com\/articles\/10.1186\/1476-4598-9-72"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,4,2]]},"references-count":23,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2010,12]]}},"alternative-id":["587"],"URL":"https:\/\/doi.org\/10.1186\/1476-4598-9-72","relation":{},"ISSN":["1476-4598"],"issn-type":[{"value":"1476-4598","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,4,2]]},"assertion":[{"value":"19 September 2009","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 April 2010","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 April 2010","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"72"}}